Research
Hormonal
Tailored treatment strategies are necessary to address the unique challenges of obesity management during menopause.
Practitioners should develop individualized obesity management plans for menopausal women.
StrongSupportsmedium confidence
Tailored treatment strategies are necessary to address the unique challenges faced by this population.
Why this rating
The claims are based on a comprehensive review of obesity management strategies.
Source
Management of obesity in menopause
Santiago Palacios et al. · Climacteric · 2024
DOI 10.1080/13697137.2024.2374760
reviewCited 13×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →